World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
30727
World Ranking
15457
National Ranking
501

Overview

Xavier Jaïs is affiliated with the University of Paris-Saclay in France, with a research portfolio primarily centered on pulmonary and cardiovascular medicine. Their work spans multiple subfields including Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Genetics, Epidemiology, and Surgery. The main focus is on topics related to Pulmonary Hypertension Research and Treatments, Cardiovascular Issues in Pregnancy, Cardiovascular Function and Risk Factors, Vascular Anomalies and Treatments, Congenital Heart Disease Studies, Venous Thromboembolism Diagnosis and Management, and Transplantation: Methods and Outcomes.

Jaïs has contributed to the medical literature through publications in several prominent venues. Frequent publication outlets include:

  • European Respiratory Journal
  • Revue des Maladies Respiratoires Actualités
  • The Journal of Heart and Lung Transplantation
  • American Journal of Respiratory and Critical Care Medicine
  • Archives of Cardiovascular Diseases Supplements

Notable recent papers authored or co-authored by Jaïs include the following:

  • "Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study," 2022, The Lancet Respiratory Medicine
  • "Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension," 2021, American Journal of Respiratory and Critical Care Medicine
  • "Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial," 2021, The Lancet Respiratory Medicine
  • "ERS statement on chronic thromboembolic pulmonary hypertension," 2020, European Respiratory Journal
  • "External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry," 2021, European Respiratory Journal

Collaboration is a key component of Jaïs's research practice, with frequent co-authors including:

  • Marc Humbert
  • David Montani
  • Olivier Sitbon
  • Laurent Savale
  • Athénaïs Boucly

With a substantial volume of scientific output in Medicine, including over 350 publications, Jaïs's work is situated at the intersection of clinical research and patient care, particularly in pulmonary hypertension and cardiovascular medicine. The publications reflect ongoing engagement with clinical trials, risk assessment methodologies, and treatment outcome studies.

Best Publications

  • Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

    Olivier Sitbon;Marc Humbert;Xavier Jaïs;Vincent Ioos

  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry

    Joanna Pepke-Zaba;Marion Delcroix;Irene Lang;Eckhard Mayer

  • Chronic thromboembolic pulmonary hypertension

    Nick H. Kim;Marion Delcroix;Xavier Jais;Michael M. Madani

  • Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

    M. Humbert;O. Sitbon;A. Yaïci;D. Montani

  • Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

    David Montani;Emmanuel Bergot;Sven Günther;Laurent Savale

  • Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers.

    Marius M. Hoeper;Stephen H. Lee;Robert Voswinckel;Massimiliano Palazzini

  • Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

    Xavier Jaïs;Andrea M. D'Armini;Pavel Jansa;Adam Torbicki

  • Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

    Athénaïs Boucly;Athénaïs Boucly;Jason Weatherald;Jason Weatherald;Laurent Savale;Laurent Savale;Xavier Jaïs;Xavier Jaïs

  • Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

    Marion Delcroix;Irene Lang;Joanna Pepke-Zaba;Pavel Jansa

  • Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

    Olivier Sanchez;Olivier Sitbon;Xavier Jaïs;Gérald Simonneau

  • Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.

    Xavier Jais;David Launay;David Launay;Azzedine Yaici;Jérôme Le Pavec

  • Pulmonary veno-occlusive disease

    David Montani;Edmund M Lau;Peter Dorfmüller;Barbara Girerd

  • Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

    Olivier Sitbon;Xavier Jaïs;Laurent Savale;Vincent Cottin

  • Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension

    Steeve Provencher;Olivier Sitbon;Marc Humbert;Ségolène Cabrol

  • Pulmonary arterial hypertension

    David Montani;Sven Günther;Peter Dorfmüller;Frédéric Perros

  • ERS statement on chronic thromboembolic pulmonary hypertension

    Marion Delcroix;Adam Torbicki;Deepa Gopalan;Olivier Sitbon

  • Pulmonary Veno-Occlusive Disease Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology

    David Montani;Lara Achouh;Peter Dorfmüller;Jérôme Le Pavec

  • Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation

    Benjamin Sztrymf;Florence Coulet;Barbara Girerd;Azzedine Yaici

  • Severe pulmonary hypertension during pregnancy: Mode of delivery and anesthetic management of 15 consecutive cases

    Martine Bonnin;Frédéric J. Mercier;Olivier Sitbon;Sandrine Roger-Christoph

Frequent Co-Authors

Marc Humbert
Marc Humbert University of Paris-Saclay
David Montani
David Montani University of Paris-Saclay
Olivier Sitbon
Olivier Sitbon University of Paris-Saclay
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Elie Fadel
Elie Fadel University of Paris-Saclay
Damien Bonnet
Damien Bonnet Université Paris Cité
Philippe Dartevelle
Philippe Dartevelle University of Luxembourg
Florent Soubrier
Florent Soubrier Université Paris Cité
Luc Mouthon
Luc Mouthon Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are many online degrees and flexible pathways available to help you build expertise or pivot within healthcare. For registered nurses looking to advance, rn to fnp programs offer a direct path to becoming a family nurse practitioner through online study, allowing you to balance your current job while learning.

Nutritional science is another growing field within healthcare, and earning an online bachelor's degree in nutrition opens doors to careers in clinical nutrition, wellness coaching, and healthcare education. Meanwhile, healthcare administration roles are in high demand. Pursuing cahme-accredited online mha programs can prepare you for leadership positions and ensure your degree meets respected industry standards.

For registered nurses who want to earn their bachelor’s without returning to campus, there are also rn to bsn no clinical hours options. These programs are ideal for working professionals seeking career growth and greater job flexibility. Whether you’re starting out in healthcare or looking to advance, these online degree options make it easier than ever to further your education and expand your career opportunities.

Best Scientists Citing Xavier Jaïs

Trending Scientists